Jaime Manzano
@jaimemanzano.bsky.social
Global health ; pharmaceutical policy ; health equity ; migration policy
Research and advocacy manager at https://saludporderecho.org/quienes-somos/
Research and advocacy manager at https://saludporderecho.org/quienes-somos/
Y el hilo hecho infografía, por aquí:
January 30, 2026 at 10:07 AM
Y el hilo hecho infografía, por aquí:
Y más de 50 años de investigación muestra que es una medida de salud pública con efecto directo en la salud, así como en los determinantes sociales de la salud: -Reduce el estrés y la ansiedad, el miedo a la deportación, mejora el sueño y la sensación de control sobre la propia vida. /1
January 30, 2026 at 9:12 AM
Y más de 50 años de investigación muestra que es una medida de salud pública con efecto directo en la salud, así como en los determinantes sociales de la salud: -Reduce el estrés y la ansiedad, el miedo a la deportación, mejora el sueño y la sensación de control sobre la propia vida. /1
Reposted by Jaime Manzano
EU's anti-racism strategy blind on immigration
EU's anti-racism strategy blind on immigration
The European Commission's updated Anti-Racism Strategy has drawn sharp criticism from civil society, who say it failed to target anti-immigrant rhetoric.
euobserver.com
January 21, 2026 at 3:22 AM
EU's anti-racism strategy blind on immigration
I’ve turned the @mbarber.bsky.social starter pack into a dedicated list you can now add to your feeds, making it much easier to stay updated on #a2m content. #idsky #medsky #tbsky #EpiSky
bsky.app/profile/did:...
bsky.app/profile/did:...
As folks transition over from the other place, I've put together a list of folks tweeting on access to medicines #a2m and pharmaceutical policy.
It’s a work in progress, esp as ppl continue to trickle in—please feel free to message me if you know someone who shd be added.
go.bsky.app/RUEiXCa
It’s a work in progress, esp as ppl continue to trickle in—please feel free to message me if you know someone who shd be added.
go.bsky.app/RUEiXCa
January 15, 2026 at 5:13 AM
I’ve turned the @mbarber.bsky.social starter pack into a dedicated list you can now add to your feeds, making it much easier to stay updated on #a2m content. #idsky #medsky #tbsky #EpiSky
bsky.app/profile/did:...
bsky.app/profile/did:...
Reposted by Jaime Manzano
Neat article that also highlights the contribution of #MSF to these changes.
"How a refugee crisis revitalised Poland’s #tuberculosis care -Poland’s approach to diagnostics, treatment, and prevention has been transformed, improving care for both refugees and Poles." www.thelancet.com/journals/lan...
"How a refugee crisis revitalised Poland’s #tuberculosis care -Poland’s approach to diagnostics, treatment, and prevention has been transformed, improving care for both refugees and Poles." www.thelancet.com/journals/lan...
How a refugee crisis revitalised Poland's tuberculosis care
Poland's approach to diagnostics, treatment, and prevention has been transformed,
improving care for both refugees and Poles. Ed Holt reports.
www.thelancet.com
January 14, 2026 at 8:39 AM
Neat article that also highlights the contribution of #MSF to these changes.
"How a refugee crisis revitalised Poland’s #tuberculosis care -Poland’s approach to diagnostics, treatment, and prevention has been transformed, improving care for both refugees and Poles." www.thelancet.com/journals/lan...
"How a refugee crisis revitalised Poland’s #tuberculosis care -Poland’s approach to diagnostics, treatment, and prevention has been transformed, improving care for both refugees and Poles." www.thelancet.com/journals/lan...
Join us today! We will explore how securitization is reshaping pharmaceutical policy in Egypt and Europe, what this shift means for transparency and democratic oversight, and how these dynamics are influencing access to medicines and transparency.
Register: events.teams.microsoft.com/event/8e601e...
Register: events.teams.microsoft.com/event/8e601e...
January 13, 2026 at 9:00 AM
Join us today! We will explore how securitization is reshaping pharmaceutical policy in Egypt and Europe, what this shift means for transparency and democratic oversight, and how these dynamics are influencing access to medicines and transparency.
Register: events.teams.microsoft.com/event/8e601e...
Register: events.teams.microsoft.com/event/8e601e...
Spain’s Supreme Court will rule on a key issue in pharma policy: are publicly funded drug prices subject to #transparency rules? The case stems from a request to disclose the price & funding terms of Luxturna (Novartis) #medsky #idsky #tbsky #healthpolicy diariofarma.com/2026/01/10/e...
El TS dirimirá el alcance de la transparencia en precios y financiación de medicamentos | @diariofarma
El Tribunal Supremo (TS) ha admitido a trámite un recurso de casación que le permitirá pronunciarse sobre el alcance de la transparencia en los precios y las condiciones de financiación de los medicam...
diariofarma.com
January 12, 2026 at 9:03 AM
Spain’s Supreme Court will rule on a key issue in pharma policy: are publicly funded drug prices subject to #transparency rules? The case stems from a request to disclose the price & funding terms of Luxturna (Novartis) #medsky #idsky #tbsky #healthpolicy diariofarma.com/2026/01/10/e...
www.nature.com/articles/s41... "In contrast, whilst #TB was ranked as the third greatest infection threat by participants in HICs, malaria and HIV/AIDS were deprioritised, with Antimicrobial Resistance (AMR) and influenza considered greater infection threats"
January 8, 2026 at 10:57 AM
www.nature.com/articles/s41... "In contrast, whilst #TB was ranked as the third greatest infection threat by participants in HICs, malaria and HIV/AIDS were deprioritised, with Antimicrobial Resistance (AMR) and influenza considered greater infection threats"
Few details on the agreement but great to see things moving forward #idsky #endtb pharma.economictimes.indiatimes.com/amp/news/pha...
Bharat Biotech, Biofabri ink tech transfer agreement for late-stage TB vaccine
TB Vaccine Development: Bharat Biotech has partnered with Biofabri to advance the late-stage TB vaccine MTBVAC, targeting widespread access in regions with high tuberculosis incidence.
pharma.economictimes.indiatimes.com
December 23, 2025 at 5:40 AM
Few details on the agreement but great to see things moving forward #idsky #endtb pharma.economictimes.indiatimes.com/amp/news/pha...
Reposted by Jaime Manzano
Hoy la Comisión de Salud Pública del Parlamento Europeo debate las enmiendas a la nueva Ley de Medicamentos Críticos.
La analizamos en esta tribuna de @agendapublica.es
agendapublica.es/noticia/2047...
La analizamos en esta tribuna de @agendapublica.es
agendapublica.es/noticia/2047...
La política del medicamento en la UE y su renuncia a la salud global
El Parlamento Europeo vota hoy la Ley de Medicamentos Críticos para frenar desabastecimientos y reducir dependencias, pero el debate se está moviendo del terreno de la salud pública al de la seguridad...
agendapublica.es
December 15, 2025 at 1:05 PM
Hoy la Comisión de Salud Pública del Parlamento Europeo debate las enmiendas a la nueva Ley de Medicamentos Críticos.
La analizamos en esta tribuna de @agendapublica.es
agendapublica.es/noticia/2047...
La analizamos en esta tribuna de @agendapublica.es
agendapublica.es/noticia/2047...
Reposted by Jaime Manzano
China leads research in 90% of crucial technologies — a dramatic shift this century www.nature.com/articles/d41...
China leads research in 90% of crucial technologies — a dramatic shift this century
The United States tops the remaining areas in an assessment of 74 technologies.
www.nature.com
December 13, 2025 at 7:24 AM
China leads research in 90% of crucial technologies — a dramatic shift this century www.nature.com/articles/d41...
An update of how the total exclusivity period would look like in the EU after the provisional agreement of the pharma package. It is not the best scenario, but still we might see generics entrying the market sooner that in the current system
December 12, 2025 at 1:02 PM
An update of how the total exclusivity period would look like in the EU after the provisional agreement of the pharma package. It is not the best scenario, but still we might see generics entrying the market sooner that in the current system
Here we go with a quick analysis
December 11, 2025 at 10:18 AM
Here we go with a quick analysis
On transparency , this is the agreement. Parliament did not manage to get its ammendment on transparency on INDIRECT funding (which is the main funding they get in the EU) @rozscourse.bsky.social
December 11, 2025 at 5:50 AM
On transparency , this is the agreement. Parliament did not manage to get its ammendment on transparency on INDIRECT funding (which is the main funding they get in the EU) @rozscourse.bsky.social
Habemus new pharmaceutical legislation in the EU www.consilium.europa.eu/en/press/pre... @thirugeneva.bsky.social @healthlawadamh.bsky.social @mattherder.bsky.social
‘Pharma package’: Council and Parliament reach a deal on new rules for a fairer and more competitive EU pharmaceutical sector
The Council and the Parliament have reached a deal on new rules to make the EU’s pharmaceutical sector fairer and more competitive.
www.consilium.europa.eu
December 11, 2025 at 5:19 AM
Habemus new pharmaceutical legislation in the EU www.consilium.europa.eu/en/press/pre... @thirugeneva.bsky.social @healthlawadamh.bsky.social @mattherder.bsky.social
Reposted by Jaime Manzano
Along with 10 other civil society organisations, we sent an open letter to the European Parliament’s Committee on Public Health, sharing recommendations to ensure that the Critical Medicines Act advances equitable access for all.
msfaccess.org/cso-open-let...
msfaccess.org/cso-open-let...
December 4, 2025 at 3:47 PM
Along with 10 other civil society organisations, we sent an open letter to the European Parliament’s Committee on Public Health, sharing recommendations to ensure that the Critical Medicines Act advances equitable access for all.
msfaccess.org/cso-open-let...
msfaccess.org/cso-open-let...
Must read "This pressure to buy companies before competitors do, to be ahead of a patent cliff, has led to a rise in the amount paid for the acquisition of companies. In turn, this has increased pressure to inflate the prices of drugs to match higher acquisition costs." www.somo.nl/the-power-to...
The power to profit without producing - SOMO
Over the past 3 decades, corporate power has expanded from control over factories and machines to control over knowledge, patents, and data. Read more.
www.somo.nl
December 4, 2025 at 8:05 PM
Must read "This pressure to buy companies before competitors do, to be ahead of a patent cliff, has led to a rise in the amount paid for the acquisition of companies. In turn, this has increased pressure to inflate the prices of drugs to match higher acquisition costs." www.somo.nl/the-power-to...
The Golden Age of Corporate Access — in an Era of Civil Society Defunding
🧵 A quick thread on what declared meetings show around the EU’s Critical Medicines Act.
🧵 A quick thread on what declared meetings show around the EU’s Critical Medicines Act.
December 3, 2025 at 1:56 PM
The Golden Age of Corporate Access — in an Era of Civil Society Defunding
🧵 A quick thread on what declared meetings show around the EU’s Critical Medicines Act.
🧵 A quick thread on what declared meetings show around the EU’s Critical Medicines Act.
Reposted by Jaime Manzano
🇪🇺 #Lobbying: How Europe’s #Business lobby took over the European Commission
The EU’s regulatory 'simplification' drive is turning into a bonanza for corporate lobbyists at the expense of #CivilSociety groups focused on areas such as the #Environment and #Health
www.euractiv.com/news/counter...
The EU’s regulatory 'simplification' drive is turning into a bonanza for corporate lobbyists at the expense of #CivilSociety groups focused on areas such as the #Environment and #Health
www.euractiv.com/news/counter...
Counterinsurgency: How Europe’s business lobby retook the Berlaymont | Euractiv
The EU’s 'simplification' drive is turning into a bonanza for corporate lobbyists
www.euractiv.com
December 2, 2025 at 6:03 PM
🇪🇺 #Lobbying: How Europe’s #Business lobby took over the European Commission
The EU’s regulatory 'simplification' drive is turning into a bonanza for corporate lobbyists at the expense of #CivilSociety groups focused on areas such as the #Environment and #Health
www.euractiv.com/news/counter...
The EU’s regulatory 'simplification' drive is turning into a bonanza for corporate lobbyists at the expense of #CivilSociety groups focused on areas such as the #Environment and #Health
www.euractiv.com/news/counter...
Today, 11 CSO sent a letter to MEPs: the Critical Medicines Act must put people first. We urge them to strengthen joint procurement to improve affordability and availability, guarantee a public return on public investment, and align EU pharmaceutical policy with global health commitments.
December 2, 2025 at 9:41 AM
Today, 11 CSO sent a letter to MEPs: the Critical Medicines Act must put people first. We urge them to strengthen joint procurement to improve affordability and availability, guarantee a public return on public investment, and align EU pharmaceutical policy with global health commitments.
Latest CHAI HIV Market Report:
📉 26,000 children with HIV missing from care
📉 PrEP initiations ↓37%
📉 HIV testing ↓8%
📉 New diagnoses ↓22%
📉 Adult loss-to-follow-up ↑10%
and in the meantime we are witnessing this unjustified regulatory strategy for LEN with many left behind #idsky
📉 26,000 children with HIV missing from care
📉 PrEP initiations ↓37%
📉 HIV testing ↓8%
📉 New diagnoses ↓22%
📉 Adult loss-to-follow-up ↑10%
and in the meantime we are witnessing this unjustified regulatory strategy for LEN with many left behind #idsky
December 2, 2025 at 9:23 AM
Latest CHAI HIV Market Report:
📉 26,000 children with HIV missing from care
📉 PrEP initiations ↓37%
📉 HIV testing ↓8%
📉 New diagnoses ↓22%
📉 Adult loss-to-follow-up ↑10%
and in the meantime we are witnessing this unjustified regulatory strategy for LEN with many left behind #idsky
📉 26,000 children with HIV missing from care
📉 PrEP initiations ↓37%
📉 HIV testing ↓8%
📉 New diagnoses ↓22%
📉 Adult loss-to-follow-up ↑10%
and in the meantime we are witnessing this unjustified regulatory strategy for LEN with many left behind #idsky
Reposted by Jaime Manzano
Noruega demostró que una transición a una cuota de mercado 100% eléctrica se puede hacer en 10 años.
Dinamarca demostrará que se puede hacer en menos.
Cambiar la fecha de 2035 para prohibir la venta de vehículos de combustión es un error.
Dinamarca demostrará que se puede hacer en menos.
Cambiar la fecha de 2035 para prohibir la venta de vehículos de combustión es un error.
Ny rekord: 91 % af alle private, der fik leveret en ny bil i november, valgte en elbil 🚗🔌
Den samlede elbilandel nåede samtidig 73,7 % – også det en klar rekord.
9 ud af de 10 mest solgte biler i november var rene elbiler (BMW X1 tæller både fossile- og elvarianter).
Den samlede elbilandel nåede samtidig 73,7 % – også det en klar rekord.
9 ud af de 10 mest solgte biler i november var rene elbiler (BMW X1 tæller både fossile- og elvarianter).
December 1, 2025 at 8:08 AM
Noruega demostró que una transición a una cuota de mercado 100% eléctrica se puede hacer en 10 años.
Dinamarca demostrará que se puede hacer en menos.
Cambiar la fecha de 2035 para prohibir la venta de vehículos de combustión es un error.
Dinamarca demostrará que se puede hacer en menos.
Cambiar la fecha de 2035 para prohibir la venta de vehículos de combustión es un error.
Reposted by Jaime Manzano
Hoy es el #DiaMundialDelSida y más que nunca hace falta tratarlo como problema global
Escribo con Phillipe Duneton @unitaid.bsky.social en @eldiario.es sobre cómo hacer que se alineen las acciones necesarias para que el VIH deje de ser una preocupación global
www.eldiario.es/opinion/trib...
Escribo con Phillipe Duneton @unitaid.bsky.social en @eldiario.es sobre cómo hacer que se alineen las acciones necesarias para que el VIH deje de ser una preocupación global
www.eldiario.es/opinion/trib...
Lecciones en la respuesta global al Sida
Una nueva herramienta tiene la capacidad de cambiar el curso de la epidemia. El lenacapavir, un medicamento de acción prolongada que requiere solo una inyección cada seis meses, es fundamental para pr...
www.eldiario.es
December 1, 2025 at 7:02 AM
Hoy es el #DiaMundialDelSida y más que nunca hace falta tratarlo como problema global
Escribo con Phillipe Duneton @unitaid.bsky.social en @eldiario.es sobre cómo hacer que se alineen las acciones necesarias para que el VIH deje de ser una preocupación global
www.eldiario.es/opinion/trib...
Escribo con Phillipe Duneton @unitaid.bsky.social en @eldiario.es sobre cómo hacer que se alineen las acciones necesarias para que el VIH deje de ser una preocupación global
www.eldiario.es/opinion/trib...
En muchos campos además (por ejemplo en CAR-T / terapias avanzadas), y con estrategias de monopolio que hasta la fecha no sabemos si difieren o no de las que los países de altos ingresos han venido esgrimiendo los últimos siglos. /1 www.transparimed.org/single-post/...
November 28, 2025 at 1:51 PM
En muchos campos además (por ejemplo en CAR-T / terapias avanzadas), y con estrategias de monopolio que hasta la fecha no sabemos si difieren o no de las que los países de altos ingresos han venido esgrimiendo los últimos siglos. /1 www.transparimed.org/single-post/...